Racing a clock somebody else set: management describes an outside deadline already driving the company's current work
The model's full reasoning — Q3 2023 call → NOWe need to determine if the company is currently working against a dated deadline set by an external party, and if the company is visibly organizing operations around that date, with the payoff on the other side. Key points from transcript: - FDA denied De Novo request in September 2023. Company filed an appeal. They expect a response from FDA by end of January 2024. That is an external deadline set by FDA's review process. The company is working to that date: they filed appeal, they are discussing comparator, they expect response by end of January. They are actively engaging with FDA. The payoff: if appeal successful, they get marketing authorization for breast cancer indication, which would open up U.S. market. That is meaningful. The reported results (Q3 2023) show costs of R&D, sales, etc., but not the revenue from that approval. So the company is preparing for that date. But is the company "currently working against" that deadline? They filed appeal, they are waiting for response. They are not necessarily racing to be ready by that date; they are waiting for FDA's decision. The deadline is for FDA to respond, not for the company to deliver something. The company is not organizing operations around hitting that date; they are awaiting a decision. The appeal is already filed. The work is done. So the company is not "working to" that date in the sense of preparing something. They are waiting. The payoff is on the other side, but the company's effort is not sequenced against that date. They are not building, hiring, training, etc. to be ready for that date. They are just waiting for a response. So that might be a NO. Another external deadline: ICE3 study completion expected in Q1 2024, following last patient's five-year follow-up. That is a study milestone, but it's not a deadline set by an external party? It's a clinical trial protocol. The company is conducting the study, but the date is determined by patient follow-up schedules. They are not working to a fixed external date; it's just when the last patient completes. They are not organizing operations around that date. They mention it as an expected completion. Not a deadline they must hit. Also, they mention regulatory approvals in Brazil, Canada, etc. But those are already obtained. Not a deadline.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| RLX | RLX Technology Inc. | Q1 2022 | 2022-05-20 | C |
| AKBA | Akebia Therapeutics, Inc. | Q3 2021 | 2021-11-09 | C+ |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
RLX · Q1 2022 → YESThe question is about whether management describes the company as currently working against a dated deadline set by someone outside the company, organizing operations around hitting that date, with th...
AKBA · Q3 2021 → YESThe question is: Does management describe the company as CURRENTLY WORKING AGAINST A DATED DEADLINE THAT SOMEBODY OUTSIDE THE COMPANY HAS SET... and organizing operations around hitting that date, wit...
EGY · Q2 2021 → YESThe question is about whether management describes the company as currently working against a dated deadline set by someone outside the company, organizing operations around hitting that date, with th...